On Thursday, Juno Therapeutics Inc (NASDAQ:JUNO)’s shares declined -2.67% to $44.89.
Juno Therapeutics Inc (JUNO) declared that it has attained Stage Cell Therapeutics GmbH (“Stage”), a privately held biotechnology company based in Munich and Gottingen, Germany. The transaction furthers Juno’s strategy of being a world leader in process development and the manufacturing of cellular therapies. The acquisition provides Juno access to transformative cell selection and activation capabilities, next generation manufacturing automation technologies, improved control of its supply chain, and lower predictable long-term cost of goods. Juno plans to operate the attained company, which employs 23 scientists, engineers, and other personnel, as a wholly-owned German partner under the name Juno Therapeutics GmbH.
Juno Therapeutics, Inc., a biopharmaceutical company, engages in developing cell-based cancer immunotherapies. The company develops cell-based cancer immunotherapies based on its chimeric antigen receptor and T cell receptor technologies to genetically engineer T cells to recognize and kill cancer cells.
Nordstrom, Inc. (NYSE:JWN)’s shares dropped -2.65% to $74.15.
Nordstrom, Inc. (JWN) declared that its board of directors approved a quarterly dividend of 37 cents per share payable on June 12, 2015, to shareholders of record at the close of business on May 29, 2015.
Nordstrom, Inc., a fashion specialty retailer, offers apparel, shoes, cosmetics, and accessories for men, women, and children in the United States and Canada. It operates through two segments, Retail and Credit.
At the end of Thursday’s trade, Ocean Rig UDW Inc (NASDAQ:ORIG)‘s shares dipped -2.52% to $8.90.
Ocean Rig UDW Inc (ORIG) declared its unaudited financial and operating results for the first quarter ended March 31, 2015.
First Quarter 2015 Financial Highlights
For the first quarter of 2015, the Company stated a net income of $41.1 million, or $0.31 basic and diluted earnings per share.
The Company stated Adjusted EBITDA(1) of $219.0 million for the first quarter of 2015, as contrast to $172.2 million for the first quarter of 2014.
- Adjusted EBITDA is a non-GAAP measure; please see later in this press release for reconciliation to net income
Recent Highlights
- On May 6, 2015, the Company’s Board of Directors declared the fifth successive quarterly cash dividend with respect to the quarter ended March 31, 2015, of $0.19 per common share, to its shareholders of record as of May 22, 2015 and payable on or about June 2, 2015.
Ocean Rig UDW Inc., an offshore drilling contractor, provides oilfield services for offshore oil and gas exploration, development, and production drilling. It specializes in the ultra-deepwater and harsh-environment segment of the offshore drilling industry.
FireEye Inc (NASDAQ:FEYE), ended its Thursday’s trading session with -2.46% loss, and closed at $42.39.
FireEye Inc (FEYE) declared participation in investment conferences for the second quarter of 2015 and replanned the 2015 Analyst Day to June 3, 2015.
- JP Morgan Global Technology, Media and Telecom Conference
Boston, MA
Presentation: Wednesday, May 20, 2015 at 8:40 a.m. EDT - Cowen & Company 43rdAnnual Technology, Media and Telecom Conference
New York City, NY
Presentation: Wednesday, May 27, 2015 at 8 a.m. EDT - Bank of America 2015 Global Technology Conference
San Francisco, CA
Presentation: Wednesday, June 3, 2015 at 8:30 a.m. PDT - 2015 Analyst Day
San Francisco, CA
Presentations: 1:00 - 4:30 p.m. PDT, Wednesday, June 3, 2015
FireEye, Inc., together with its auxiliaries, provides cybersecurity solutions for detecting, preventing, and resolving cyber-attacks. The company offers vector-specific appliance solutions that provide threat protection from network to endpoint for inbound and outbound network traffic that may contain sensitive information.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
